Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib for Age-Associated Memory Impairment
NCT00009230Phase 3Completed
- Sponsor
- University of California, Los Angeles
- Start
- Jun 2000
- Primary completion
- Jun 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of celecoxib in Age-associated memory impairment (AAMI), sponsored by University of California, Los Angeles. Started Jun 2000; status: completed.
02
Drugs
celecoxib
03
Conditions
Age-associated memory impairment (AAMI)
Beyond the preview
Go deeper on NCT00009230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00009230.